Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_assertion description "[An ongoing phase II, double blind, placebo-controlled study is evaluating farletuzumab in patients with FOLR1 expressing metastatic adenocarcinoma of lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_assertion evidence source_evidence_literature NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_assertion SIO_000772 23357463 NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_assertion wasDerivedFrom befree-2016 NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_assertion wasGeneratedBy ECO_0000203 NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1047833.RAjNA7tflKH017TKq71t4b1_Y8LGBecOE_dlSDESyN-K8130_provenance.